The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Han, K. T.
Right arrow Articles by Winn, R. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Han, K. T.
Right arrow Articles by Winn, R. K.

The Journal of Immunology, Vol 155, Issue 8 4011-4015, Copyright © 1995 by American Association of Immunologists


ARTICLES

Sialyl Lewis(x) oligosaccharide reduces ischemia-reperfusion injury in the rabbit ear

KT Han, SR Sharar, ML Phillips, JM Harlan and RK Winn
Department of Plastic and Reconstructive Surgery, Catholic University Medical College, Seoul, Korea.

Ischemia-reperfusion injury in the rabbit ear is neutrophil (PMN)- mediated, and is significantly reduced by anti-adhesion agents directed against beta 2 integrins, P-selectin, or L-selectin. We further examined selectin-mediated adherence in this setting following the administration of soluble sialyl Lewis(x) (SLe(x)), the principal carbohydrate ligand for P-, L-, and E-selectin, at various times following reperfusion. Under constant ambient temperature conditions, the rabbit ear vascular supply was isolated and occluded with an atraumatic vascular clamp for 6 h, then allowed to reperfuse. Animals receiving i.v. SLe(x) (25 mg/kg bolus + 50 mg/kg infusion over 10 h) 1) at the time of reperfusion, 2) 1 h after reperfusion, 3) 4 h after reperfusion, or 4) 12 h after reperfusion were compared with control animals receiving either saline or sialyl lactosamine, an oligosaccharide structurally similar to SLe(x) but not involved in selectin recognition. Tissue injury was assessed by serial measurement of ear edema and by visual determination of ear necrosis over 7 days. Tissue edema and necrosis were significantly reduced in animals treated with SLe(x) immediately upon reperfusion or after a 1-h delay, but not in animals for whom SLe(x) administration was delayed by 4 or 12 h. Furthermore, SLe(x) administration alone had no effect on circulating leukocyte or PMN counts, or PMN expression of CD18 or L-selectin. We conclude that interruption of selectin-mediated adherence with soluble SLe(x) oligosaccharide attenuates reperfusion in the rabbit ear. The observation that SLe(x) is efficacious only if administered in the first hour after reperfusion suggests that the more immediately available P- and L-selectin participate in this PMN adhesion/injury process, whereas E-selectin, with its delayed endothelial expression, does not.


This article has been cited by other articles:


Home page
Appl. Environ. Microbiol.Home page
Y.-i. Shimma, F. Saito, F. Oosawa, and Y. Jigami
Construction of a Library of Human Glycosyltransferases Immobilized in the Cell Wall of Saccharomyces cerevisiae
Appl. Envir. Microbiol., November 1, 2006; 72(11): 7003 - 7012.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
M. L. Schermerhorn, D. P. Nelson, E. D. Blume, L. Phillips, and J. E. Mayer Jr
Sialyl LewisX oligosaccharide preserves myocardial and endothelial function during cardioplegic ischemia
Ann. Thorac. Surg., September 1, 2000; 70(3): 890 - 894.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
M. L. Schermerhorn, M. Tofukuji, P. R. Khoury, L. Phillips, P. R. Hickey, F. W. Sellke, J. E. Mayer Jr, and D. P. Nelson
Sialyl LewisX oligosaccharide preserves cardiopulmonary and endothelial function after hypothermic circulatory arrest in lambs
J. Thorac. Cardiovasc. Surg., August 1, 2000; 120(2): 230 - 237.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
S. Toppila, T. Paavonen, M. S. Nieminen, P. Hayry, and R. Renkonen
Endothelial L-Selectin Ligands Are Likely to Recruit Lymphocytes into Rejecting Human Heart Transplants
Am. J. Pathol., October 1, 1999; 155(4): 1303 - 1310.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
T. Shin'oka, M. Nagashima, G. Nollert, D. Shum-Tim, P. C. Laussen, H. G. W. Lidov, A. d. Plessis, and R. A. Jonas
A NOVEL SIALYL LEWIS X ANALOG ATTENUATES CEREBRAL INJURY AFTER DEEP HYPOTHERMIC CIRCULATORY ARREST
J. Thorac. Cardiovasc. Surg., June 1, 1999; 117(6): 1204 - 1211.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. K. Barron, R. S. Lake, A. J. Buda, and A. N. Tenaglia
Intimal Hyperplasia After Balloon Injury Is Attenuated by Blocking Selectins
Circulation, November 18, 1997; 96(10): 3587 - 3592.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
J. P. Williams, M. R. Weiser, T. T. V. Pechet, L. Kobzik, F. D. Moore Jr., and H. B. Hechtman
alpha 1-Acid glycoprotein reduces local and remote injuries after intestinal ischemia in the rat
Am J Physiol Gastrointest Liver Physiol, November 1, 1997; 273(5): G1031 - G1035.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. K. Sarkar, K. S. Rostand, R. K. Jain, K. L. Matta, and J. D. Esko
Fucosylation of Disaccharide Precursors of Sialyl LewisX Inhibit Selectin-mediated Cell Adhesion
J. Biol. Chem., October 10, 1997; 272(41): 25608 - 25616.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
T. Ueyama, H. Ikeda, N. Haramaki, K. Kuwano, and T. Imaizumi
Effects of Monoclonal Antibody to P-Selectin and Analogue of Sialyl Lewis X on Cyclic Flow Variations in Stenosed and Endothelium-Injured Canine Coronary Arteries
Circulation, March 18, 1997; 95(6): 1554 - 1559.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1995 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1995 by The American Association of Immunologists, Inc. All rights reserved.